• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦军队医院中产 NDM-1 碳青霉烯酶肠杆菌科细菌的粪便携带率,以及两种显色培养基的评估。

Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media.

机构信息

Microbiology Department, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK.

出版信息

J Antimicrob Chemother. 2011 Oct;66(10):2288-94. doi: 10.1093/jac/dkr299. Epub 2011 Jul 25.

DOI:10.1093/jac/dkr299
PMID:21788293
Abstract

OBJECTIVES

To determine the prevalence and antimicrobial susceptibility of carbapenemase-producing Enterobacteriaceae among hospitalized patients and outpatients attending two military hospitals in Rawalpindi, Pakistan, and to compare the performance of two chromogenic culture media for the isolation of these organisms.

METHODS

Stool samples from 200 distinct patients were cultured on MacConkey agar and subsequently on two chromogenic media-Colorex KPC and a prototype chromogenic medium, ID Carba-designed for the isolation of carbapenemase-producing Enterobacteriaceae. All Gram-negative isolates growing on either chromogenic medium were investigated for carbapenemases by phenotypic and molecular methods. Producers were subjected to susceptibility testing with 40 antimicrobials by VITEK 2 or agar dilution.

RESULTS

In total, 64 NDM-1-positive isolates of Enterobacteriaceae, belonging to seven distinct species, were recovered from 37 (18.5%) of the stool samples. No other carbapenemase types were confirmed. Nineteen positive samples were identified among 70 from inpatients (prevalence 27.1%) and there were 18 positive samples among 130 from outpatients (prevalence 13.8%). Fifty-six isolates (87.5%) harbouring the NDM-1 enzyme were recovered on ID Carba compared with 41 isolates (64.1%) on Colorex KPC (P = 0.012). Multidrug resistance was prevalent, but no pan-resistant isolates were found, with most isolates susceptible in vitro to colistin (97%), mecillinam (95%), fosfomycin (94%), tigecycline (89%) and nitrofurantoin (78%).

CONCLUSIONS

This study shows a high prevalence of multidrug-resistant Enterobacteriaceae with the NDM-1 enzyme in Rawalpindi. The new chromogenic medium, ID Carba, was more sensitive than Colorex KPC and has potential as a screening medium for isolation of Enterobacteriaceae harbouring the NDM-1 enzyme.

摘要

目的

确定巴基斯坦拉瓦尔品第的两家军队医院住院患者和门诊患者中产碳青霉烯酶肠杆菌科的流行率和抗菌药物敏感性,并比较两种显色培养基在分离这些生物体方面的性能。

方法

对 200 名不同患者的粪便样本进行培养,先在麦康凯琼脂上培养,然后再在两种显色培养基上培养-显色培养基科雷克斯 KPC 和一种用于分离产碳青霉烯酶肠杆菌科的原型显色培养基 ID Carba。对两种显色培养基上生长的所有革兰氏阴性分离株均通过表型和分子方法进行碳青霉烯酶检测。通过 VITEK 2 或琼脂稀释法对产酶株进行 40 种抗菌药物的药敏试验。

结果

总共从 37 份(18.5%)粪便样本中回收了属于七种不同种属的 64 株 NDM-1 阳性肠杆菌科。没有确认其他碳青霉烯酶类型。从 70 名住院患者的 19 份阳性样本(患病率 27.1%)和 130 名门诊患者的 18 份阳性样本(患病率 13.8%)中发现。在 ID Carba 上回收了 56 株(87.5%)携带 NDM-1 酶的分离株,而在科雷克斯 KPC 上回收了 41 株(64.1%)(P = 0.012)。多药耐药性很普遍,但未发现泛耐药株,大多数分离株对体外多粘菌素(97%)、美西林(95%)、磷霉素(94%)、替加环素(89%)和呋喃妥因(78%)敏感。

结论

本研究显示拉瓦尔品第地区产 NDM-1 酶的多重耐药肠杆菌科的流行率很高。新型显色培养基 ID Carba 比科雷克斯 KPC 更敏感,具有作为分离携带 NDM-1 酶的肠杆菌科的筛选培养基的潜力。

相似文献

1
Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media.巴基斯坦军队医院中产 NDM-1 碳青霉烯酶肠杆菌科细菌的粪便携带率,以及两种显色培养基的评估。
J Antimicrob Chemother. 2011 Oct;66(10):2288-94. doi: 10.1093/jac/dkr299. Epub 2011 Jul 25.
2
Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media.巴基斯坦一家军队医院产 NDM-1 碳青霉烯酶肠杆菌科的流行情况和分子特征,以及两种显色培养基的评估。
Diagn Microbiol Infect Dis. 2013 Feb;75(2):187-91. doi: 10.1016/j.diagmicrobio.2012.11.006. Epub 2012 Dec 14.
3
New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.肠杆菌科细菌中的新德里金属β-内酰胺酶(NDM-1):碳青霉烯类药物的治疗选择受到影响。
J Assoc Physicians India. 2010 Mar;58:147-9.
4
Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.泰国产 NDM-1 和 IMP-14a 型肠杆菌科细菌的出现。
J Antimicrob Chemother. 2012 Nov;67(11):2626-30. doi: 10.1093/jac/dks267. Epub 2012 Jul 13.
5
Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures.CHROMagar™ KPC 用于直肠监测培养中产碳青霉烯酶肠杆菌科的检测评估。
Int J Antimicrob Agents. 2011 Feb;37(2):124-8. doi: 10.1016/j.ijantimicag.2010.10.010. Epub 2010 Dec 21.
6
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.产 NDM-1 肠杆菌科细菌体外抗生素协同作用评价。
J Antimicrob Chemother. 2011 Oct;66(10):2295-7. doi: 10.1093/jac/dkr296. Epub 2011 Aug 1.
7
NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.阿曼苏丹国产 NDM-1、OXA-48 和 OXA-181 碳青霉烯酶肠杆菌科细菌。
Clin Microbiol Infect. 2012 May;18(5):E144-8. doi: 10.1111/j.1469-0691.2012.03796.x. Epub 2012 Mar 8.
8
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.针对碳青霉烯类耐药肠杆菌科细菌,还有哪些选择?氯霉素、环丙沙星、黏菌素、磷霉素、米诺环素、呋喃妥因、替莫西林和替加环素的评估。
Int J Antimicrob Agents. 2011 May;37(5):415-9. doi: 10.1016/j.ijantimicag.2011.01.012. Epub 2011 Mar 22.
9
Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.比利时 24 家医院肠杆菌科分离株中产碳青霉烯酶的流行情况及其耐药机制。
J Antimicrob Chemother. 2013 Aug;68(8):1832-7. doi: 10.1093/jac/dkt096. Epub 2013 Apr 3.
10
High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco.摩洛哥一所大学医院中产Extended-spectrum β-lactamase 和 OXA-48 carbapenemase 的肠杆菌科的高粪便携带率。
Clin Microbiol Infect. 2014 Apr;20(4):350-4. doi: 10.1111/1469-0691.12325. Epub 2013 Aug 9.

引用本文的文献

1
treatment strategies: a review of therapeutic challenges and considerations.治疗策略:治疗挑战与考量综述
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0106324. doi: 10.1128/aac.01063-24. Epub 2025 Jul 9.
2
Antibiotic resistance pattern of multidrug-resistant Enterobacterales from a rectal surveillance study in northern Nigeria.尼日利亚北部一项直肠监测研究中多重耐药肠杆菌科细菌的抗生素耐药模式
Int Health. 2025 Sep 3;17(5):769-777. doi: 10.1093/inthealth/ihaf026.
3
Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant .
对碳青霉烯类耐药菌的抗菌联合治疗进行基因组分析和体外评估。
Medicina (Kaunas). 2024 Jul 2;60(7):1086. doi: 10.3390/medicina60071086.
4
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.头孢地尔罗治疗严重需氧革兰氏阴性细菌感染:技术评估以提供一种新的订阅式支付模式。
Health Technol Assess. 2024 Jun;28(28):1-238. doi: 10.3310/YGWR4511.
5
The Rising Tide of Antibiotic Resistance: A Study on Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae.抗生素耐药性的兴起:对产超广谱β-内酰胺酶和碳青霉烯类耐药的大肠埃希菌和肺炎克雷伯菌的研究。
J Clin Lab Anal. 2024 May;38(10):e25081. doi: 10.1002/jcla.25081. Epub 2024 Jun 17.
6
New Delhi metallo-β-lactamases among extensively drug-resistant clinical isolates from Lahore, Pakistan.巴基斯坦拉合尔地区广泛耐药临床分离株中的新德里金属β-内酰胺酶。
Future Microbiol. 2024;19(11):971-981. doi: 10.1080/17460913.2024.2343600. Epub 2024 Jun 17.
7
A systematic review and meta-analysis of carbapenem resistance and its possible treatment options with focus on clinical : Thirty years of development in Pakistan.碳青霉烯类耐药性及其可能的治疗选择的系统评价和荟萃分析:以巴基斯坦三十年的发展为重点,聚焦临床
Heliyon. 2024 Mar 17;10(7):e28052. doi: 10.1016/j.heliyon.2024.e28052. eCollection 2024 Apr 15.
8
Fecal Carriage of Carbapenem Resistant and Associated Factors Among Admitted Patients in Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴圣保罗医院千禧医学院住院患者中耐碳青霉烯类药物的粪便携带情况及相关因素
Infect Drug Resist. 2023 Sep 26;16:6345-6355. doi: 10.2147/IDR.S418066. eCollection 2023.
9
Whole genome-based genetic insights of producing clinical isolates in hospital settings of Pakistan.基于全基因组的巴基斯坦医院环境中临床分离株产生的遗传见解。
Microbiol Spectr. 2023 Sep 5;11(5):e0058423. doi: 10.1128/spectrum.00584-23.
10
Detection of NDM-1 and OXA-10 Co-Producing Clinical Isolate.NDM-1和OXA-10共产生临床分离株的检测
Infect Drug Resist. 2023 Aug 15;16:5319-5328. doi: 10.2147/IDR.S418131. eCollection 2023.